The study found that by using this ultrasound technology on test mice, a 75% memory function was fully restored.

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

BURLINGTON, N.C., Oct. 23, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the ...

The earlier Alzheimer’s disease can be diagnosed, the better the outcomes; however, it can be hard to diagnose the disease in its earliest stages. The United States Food and Drug Administration ...

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is the first blood test aiding Alzheimer's diagnosis by detecting amyloid plaques, offering a less invasive alternative to PET scans. The test ...

Please provide your email address to receive an email when new articles are posted on . Labcorp said its national network can ease burdens of access to testing for Alzheimer’s disease. Blood-based ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. Developed by Fujirebio, the Lumipulse G test measures ...

Disclosure of amyloid‑beta PET results to inform cognitively unimpaired older adults about their risk for dementia was not associated with significant changes in self‑reported health behaviors 7 ...

These findings — from a blood test to improvements in drug delivery — may lead to better diagnosis and treatment of the ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment. Toxic proteins quietly collect inside cells, support cells turn restless, and ...